Camber Capital Management as of March 31, 2020
Portfolio Holdings for Camber Capital Management
Camber Capital Management holds 29 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 8.8 | $148M | 1.7M | 89.79 | |
| Change Healthcare | 7.8 | $130M | 13M | 9.99 | |
| Mylan Nv | 6.9 | $116M | 7.8M | 14.91 | |
| GlaxoSmithKline | 6.8 | $114M | 3.0M | 37.89 | |
| Universal Health Services (UHS) | 6.7 | $112M | 1.1M | 99.08 | |
| Perrigo Company (PRGO) | 5.7 | $96M | 2.0M | 48.09 | |
| Abbvie (ABBV) | 5.5 | $91M | 1.2M | 76.19 | |
| Alkermes (ALKS) | 5.2 | $87M | 6.1M | 14.42 | |
| Ventas (VTR) | 5.2 | $87M | 3.3M | 26.80 | |
| Hca Holdings (HCA) | 4.6 | $76M | 850k | 89.85 | |
| Sarepta Therapeutics (SRPT) | 4.2 | $71M | 725k | 97.82 | |
| Biogen Idec (BIIB) | 3.8 | $63M | 200k | 316.38 | |
| Ascendis Pharma A S (ASND) | 3.6 | $60M | 537k | 112.61 | |
| Momenta Pharmaceuticals | 3.2 | $54M | 2.0M | 27.20 | |
| Nektar Therapeutics (NKTR) | 3.2 | $54M | 3.0M | 17.85 | |
| Brookdale Senior Living (BKD) | 3.2 | $53M | 17M | 3.12 | |
| Tenet Healthcare Corporation (THC) | 3.0 | $50M | 3.5M | 14.40 | |
| Myriad Genetics (MYGN) | 2.0 | $34M | 2.4M | 14.31 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.0 | $33M | 2.0M | 16.33 | |
| AMAG Pharmaceuticals | 1.6 | $27M | 4.4M | 6.18 | |
| Incyte Corporation (INCY) | 1.6 | $26M | 361k | 73.23 | |
| Avrobio Ord (AVRO) | 1.3 | $21M | 1.4M | 15.56 | |
| Translate Bio | 1.1 | $18M | 1.8M | 9.97 | |
| Puma Biotechnology (PBYI) | 1.0 | $17M | 2.0M | 8.44 | |
| Atara Biotherapeutics (ATRA) | 0.8 | $13M | 1.5M | 8.51 | |
| Glycomimetics (GLYC) | 0.5 | $8.0M | 3.5M | 2.28 | |
| Pacific Biosciences of California (PACB) | 0.5 | $7.7M | 2.5M | 3.06 | |
| Sutro Biopharma (STRO) | 0.4 | $6.1M | 600k | 10.20 | |
| NuVasive | 0.1 | $1.7M | 34k | 50.67 |
